UnitedHealth stock is deeply oversold, undervalued, and primed for a recovery. Read why analysts forecast UNH to have a ~29% ...

Sarepta Therapeutics (SRPT) said a third patient has died from acute liver failure after receiving one of its gene therapies, ...

ABT, which had been outperforming the healthcare cohort from the S&P 500 and the S&P 500 itself all through this year, has ...

The Federal Trade Commission set aside orders barring Hess CEO John Hess from joining Chevron's board and former Pioneer ...

Property REITs remain attractive despite high rates, with low leverage, fixed-rate debt, and strong income growth. Read more ...

The direct lending market has experienced dramatic growth and become a vital and growing part of institutional investors’ ...

ProShares Ultra S&P500 ETF offers leveraged exposure, amplifying both gains and losses. Read why we do not recommend SSO as a ...

Charles Schwab (SCHW) stock climbed 2.2% in Friday premarket trading after Q2 earnings and revenue beat Wall Street ...

Select Medical remains a soft 'buy' amid organic growth and solid performance, despite risks like Medicaid changes and recent ...

Canadian Natural is a high cash flow, low-cost producer with strong returns and further opportunities to expand its ...

Trump is unlikely to further delay tariffs; significantly higher tariffs will be imposed on August 1st. Read why investors ...

Learn why the US Dollar's decline highlights the importance of international diversification for dividend investors.